Data-mining and analytics company Palantir (NYSE:PLTR) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 39.3% year on year to $883.9 million. On top of that, next quarter’s revenue guidance ($936 million at the midpoint) was surprisingly good and 4.2% above what analysts were expecting. Its non-GAAP profit of $0.13 per share was in line with analysts’ consensus estimates.
Online insurance comparison site EverQuote (NASDAQ:EVER) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 83% year on year to $166.6 million. On top of that, next quarter’s revenue guidance ($157.5 million at the midpoint) was surprisingly good and 5.4% above what analysts were expecting. Its GAAP profit of $0.21 per share was 36.4% below analysts’ consensus estimates.
Consumer products giant Clorox (NYSE:CLX) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 8% year on year to $1.67 billion. Its non-GAAP profit of $1.45 per share was 6.9% below analysts’ consensus estimates.
Online work marketplace Upwork (NASDAQ:UPWK) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales were flat year on year at $192.7 million. The company expects next quarter’s revenue to be around $186.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.27 per share was in line with analysts’ consensus estimates.
Semiconductor designer Lattice Semiconductor (NASDAQ:LSCC) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 14.7% year on year to $120.2 million. The company expects next quarter’s revenue to be around $123.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.22 per share was in line with analysts’ consensus estimates.
Medical technology company Inspire Medical Systems (NYSE:INSP) announced better-than-expected revenue in Q1 CY2025, with sales up 22.7% year on year to $201.3 million. The company expects the full year’s revenue to be around $947.5 million, close to analysts’ estimates. Its GAAP profit of $0.10 per share was significantly above analysts’ consensus estimates.
Shares of healthcare services company Sotera Health (NASDAQ:)
jumped 5.9% in the pre-market session after Goldman Sachs analyst Matthew Sykes upgraded the stock from Neutral to Buy and raised the price target from $14 to $17. Sykes emphasized that SHC's consistent exposure to the commercial pharmaceutical and medical device sectors, both of which are considered essential and relatively insulated from economic cycles, positions the company as a more compelling investment amid growing macroeconomic uncertainty.
Shares of cloud communications infrastructure company Twilio (NYSE:TWLO)
jumped 5.6% in the afternoon session after HSBC upgraded the stock from Sell to Hold and raised the price target from $77 to $99. Following TWLO's Q1 2025 earnings, the firm highlighted "signs of revenue growth revival.".
Shares of analog chips maker onsemi (NASDAQ:ON)
fell 8% in the afternoon session after the company posted underwhelming results for the first quarter of 2025, with sales down 22% from the previous year. Each of its main business lines (power, analog, and sensing) saw big drops. Another concern was the big hit to profit margins due to write-downs on stock and factory assets.
Even though sales tumbled, the firm still beat earnings forecasts.
For next quarter, the company expects sales to stay flat (q/q) and margins to bounce back a little, though still far from last year's levels. All told, it was a weak quarter.
Expedia faces headwinds from soft U.S. travel trends, with first-quarter nights growth expected at 5%. Despite lowered forecasts, BofA Securities still sees upside, maintaining a Buy rating on EXPE stock.
B of A Securities analyst maintains Buy rating on Chevron Corp. despite mixed Q1 earnings. Reiterates attractive investment due to strong cash flow and financial position. RBC Capital Markets also rates CVX Outperform with $175 price target.
